Revolution Medicines, Inc. (RVMD)
Revolution Medicines, Inc. (RVMD) is a Healthcare stock tracked by StreetAlpha. RVMD reports earnings on Wed, Nov 4, 2026. The average 12-month price target from 16 analysts is $257.44, with a high of $320.00 and a low of $179.00. Analyst consensus is Strong Buy, based on the latest ratings from 16 firms (15 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in RVMD, 50% of them bullish and 50% bearish. In the past 30 days there were 8 dark pool prints totaling $20.8M, the largest $5.5M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 16 analysts who set a price target on RVMD in the past 90 days. The average target is $257.44, with a high of $320.00 and a low of $179.00.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 28 | Brookline Capital | Initiated | Buy | $318 |
| Sep 24 | Goldman Sachs | Reinstated | Buy | $267 |
| Sep 21 | B of A Securities | Maintained | Buy | $265 |
| Sep 10 | Morgan Stanley | Initiated | Buy | $255 |
| Sep 9 | Stifel | Target raised | Buy | $85 → $230 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RVMD is in one of them and how their past RVMD trades turned out.
RVMD News & Analysis
All StreetAlpha news →For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.